COMPARISON BETWEEN VAGAL MANEUVERS AND ADENOSINE IN PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
DOI:
https://doi.org/10.56238/levv17n58-079Keywords:
Paroxysmal Supraventricular Tachycardia, Vagal Maneuvers, Valsalva Maneuver, Adenosine, Cardiac ArrhythmiasAbstract
Paroxysmal supraventricular tachycardia (PSVT) is one of the most common arrhythmias in clinical practice, characterized by sudden episodes of supraventricular tachycardia. The management of this condition in hemodynamically stable patients is initially based on the use of vagal maneuvers, followed by adenosine administration in cases of failure. This study aimed to compare the effectiveness, safety, and clinical applicability of vagal maneuvers and adenosine in the treatment of PSVT through an integrative literature review. The search was conducted in the PubMed/MEDLINE, SciELO, and ScienceDirect databases, considering studies published between 2015 and 2025, using controlled descriptors and free terms in combination. Randomized clinical trials, systematic reviews, meta-analyses, and clinical guidelines addressing the management of PSVT were included. The results demonstrated that vagal maneuvers present variable efficacy, generally with success rates below 50%, whereas adenosine showed reversal rates above 80–90%. The modified Valsalva maneuver showed higher effectiveness compared to the standard technique, although still inferior to adenosine. It is concluded that, although vagal maneuvers are recommended as first-line therapy due to their safety and ease of application, adenosine stands out as the most effective strategy for restoring sinus rhythm and should be used after the failure of non-pharmacological interventions.
Downloads
References
ALABED, S. et al. Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia. Cochrane Database of Systematic Reviews, 2017. DOI:10.1002/14651858.CD005154.pub3.
APPELBOAM, A. et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. The Lancet, v. 386, n. 10005, p. 1747–1753, 2015. DOI: 10.1016/S0140-6736(15)61485-4.
ABDULHAMID, M. et al. Modified Valsalva maneuver versus standard Valsalva maneuver for supraventricular tachycardia: systematic review and meta-analysis. The American Journal of Emergency Medicine, 2021. DOI: 10.1016/j.ajem.2021.03.017.
BICILIOĞLU, Y. et al. Supraventricular tachycardia treatment in the pediatric emergency department: adenosine versus vagal maneuvers. Journal of Pediatric Emergency Care, 2020. DOI: 10.1097/PEC.0000000000001841.
BRADY, W. J. et al. Treatment of out-of-hospital supraventricular tachycardia: adenosine versus vagal maneuvers. Prehospital Emergency Care, 1996.
BRUGADA, J. et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. European Heart Journal, v. 41, n. 5, p. 655–720, 2020. DOI: 10.1093/eurheartj/ehz467.
DAENGBUBPHA, S. et al. Comparing methods of adenosine administration in supraventricular tachycardia: a randomized controlled trial. The American Journal of Emergency Medicine, 2022. DOI: 10.1016/j.ajem.2022.02.010.
HUANG, Y. et al. Comparison of various vagal maneuvers for supraventricular tachycardia: a network meta-analysis. The American Journal of Emergency Medicine, 2022. DOI:10.1016/j.ajem.2021.12.024.
IMMANUEL, A. et al. Pursuit of optimal vagal maneuvers in stable supraventricular tachycardia: a network meta-analysis. The Journal of Emergency Medicine, 2025. DOI:10.1016/j.jemermed.2024.10.012.
KOTRUCHIN, P. et al. Comparison between the double-syringe and standard technique of adenosine administration in supraventricular tachycardia. The American Journal of Emergency Medicine, 2022. DOI: 10.1016/j.ajem.2021.12.067.
LATIȘ, O. et al. Vagal maneuvers in treating acute supraventricular tachycardia: a review. Medicina, v. 59, n. 2, 2023. DOI: 10.3390/medicina59020346.
LIM, S. H. et al. Randomised controlled trial assessing head-down deep breathing versus modified Valsalva maneuver for supraventricular tachycardia. European Journal of Emergency Medicine, 2021. DOI: 10.1097/MEJ.0000000000000797.
LODEWYCKX, S.; BERGS, J. Effectiveness of the modified Valsalva manoeuvre in adults with supraventricular tachycardia: a systematic review. European Journal of Emergency Medicine, 2021. DOI: 10.1097/MEJ.0000000000000792.
LU, X. et al. Efficacy and safety of modified Valsalva maneuver for supraventricular tachycardia: a meta-analysis. The American Journal of Emergency Medicine, 2024. DOI: 10.1016/j.ajem.2023.10.012.
PAGE, R. L. et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia. Circulation, v. 133, n. 14, p. e506–e574, 2016. DOI: 10.1161/CIR.0000000000000311.
PAN, X. et al. Managing supraventricular tachyarrhythmia in pregnant patients: clinical outcomes. BMC Cardiovascular Disorders, 2024. DOI: 10.1186/s12872-024-03789-1.
SMITH, G. et al. Effectiveness of the Valsalva manoeuvre for reversion of supraventricular tachycardia. Cochrane Database of Systematic Reviews, 2015. DOI: 10.1002/14651858.CD009502.pub2.
XIAO, Y. et al. Combined modified Valsalva maneuver with adenosine versus adenosine alone in supraventricular tachycardia. The American Journal of Emergency Medicine, 2024. DOI: 10.1016/j.ajem.2024.01.045.
ZOU, Y. et al. Current practices and knowledge of adenosine use in supraventricular tachycardia. BMC Emergency Medicine, 2025. DOI: 10.1186/s12873-025-01025-4.
